LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 Diabetes

Monday, January 9, 2012 1 min read

Key Takeaway: LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 Diabetes